
    
      The study was conducted as an open label, balanced, randomised, two-treatment, two-period,
      two-sequence, single-dose, crossover , bioequivalence study on Doxycycline monohydrate
      comparing Doxycycline monohydrate 100mg tablets of Ranbaxy Pharmaceuticals Inc with Adoxa Â®
      100 mg tablets of Bradley Pharmaceuticals Inc. in healthy, adult, human, subjects under fed
      conditions.

      A total of 32 non-smoking subjects (21 men and 11 women) were included in this study, of
      which 32 finished the study according to the protocol.
    
  